Functional Interaction between TGF-β and IL-12 in Human Primary Allogeneic Cytotoxicity and Proliferative Response

Journal of Immunology

Volumn 158, Issue 1, 1997, Pages 136-143

  Pardoux, Cécile ^a   Asselin Paturel, Carine ^a   Chehimi, Jihed ^b   Gay, Françoise ^a   Mami Chouaib, Fathia ^a   Chouaib, Salem ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BIOSYNTHESIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIXED LYMPHOCYTE CULTURE;

ADULT; CYTOTOXICITY, IMMUNOLOGIC; DRUG SYNERGISM; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; ISOANTIGENS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; RECEPTORS, INTERLEUKIN; T-LYMPHOCYTES, CYTOTOXIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030639108     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Chouaib, S., A. Bensussan, A. Termijtelen, M. Andreef, C. Marchiol-Fournigault, D. Fradelizi, and B. Dupont. 1988. Allogeneic T cell activation triggering by MHC class I antigens. J. Immunol. 141:423.
2. Chehimi, J., and O. Trinchieri. 1994. Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol. 14:149.
3. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
4. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of IFN gamma production by NK cell stimulatory factor (NKSF): characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869.
5. + T lymphocytes, and NK cells. J. Immunol. 149:3495.
6. Valiante, N. M., M. Rengaraju, and G. Trinchieri. 1992. Role of the production of natural killer cell stimulatory factor (NKSF/IL-12) in the ability of B cell lines to stimulate T and NK cell proliferation. Cell. Immunol. 145:187.
7. Naume, B., M. K. Gately, B. B. Desai, A. Sundan, and T. Espevik. 1993. Synergistic effects of imerleukin-4 and interleukin-12 on NK cell proliferation. Cytokine 5:38.
8. + natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Eur. J. Immunol. 23:1831.
9. Aste-Amezaga, M., A. D'Andrea, M. Kubin, and G. Trinchieri. 1994. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell. Immunol. 156:480.
10. Robertson, M. J., R. J. Soiffer, S. F. Wolf, T. J. Manley, C. Donahue, D. Young, S. H. Hermann, and J. Ritz. 1992. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175:779.
11. Chehimi, J., S. E. Starr, I. Frank, M. Rengaraju, S. J. Jackson, C. Llanes, M. Kobayashi, B. Perussia, D. Young, E. Nickbarg, S. F. Wolf, and G. Trinchieri. 1992. Natural killer cell stimulatory factor (NKSF) increases the cytotoxic activity of NK cells from both healthy donors and HIV-infected patients. J. Exp. Med. 175:789.
12. + NK cells. J. Immunol. 148:2429.
13. Chehimi, J., N. M. Valiante, A. D'Andrea, M. Rengaraju, Z. Rosado, M. Kobayashi, B. Perussia, S. F. Wolf, S. E. Starr, and G. Trinchieri. 1993. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur. J. Immunol. 23:1826.
14. Gately, M. K., A. G. Wolitzky, P. M. Quinn, and R. Chizzonite. 1992. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 143: 127.
15. + T lymphocytes. J. Immunol. 151:2444.
16. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of Th1 cells. Immunol. Today 14:335.
17. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccini, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin-12 (IL-12)) induces (Th1)-type specific immune responses and inhibits the development of IL-4 producing Th2 cells. J. Exp. Med. 177:1199.
18. Clerici, M., D. R. Lucev, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721.
19. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin-12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361.
20. Desai, B. B., P. M. Quinn, A. G. Wolitzki, P. K. Mongini, R. Chizzonite, and M. K. Gately. 1992. IL-12 receptor. II. Distribution and regulation of receptor expression. J. Immunol. 148:3125.
21. Chizzonite, R., T. Truitt, B. B. Desai, P. Nunes, F. J. Podlaski, A. S. Stern, and M. K. Gately. 1992. IL-12 receptor. I. Characterization of the receptor on phytohemagglutinin-activaled human lymphoblasts. J. Immunol. 148:3117.
22. Chouaib, S., B. Escudier, and J. Chehimi. 1996. Interleukin-12, cellular and molecular immunology of an important regulatory cytokine (New York, 9-12, November 1995). Eur. Cytokine Netw. 7:79.
23. Chua, A. O., R. Chizzonite, B. B. Desai, T. P. Truitt, P. Nunes, L. J. Minetti, R. R. Warner, D. H. Presky, J. F. Levine, M. K. Gately, and U. Gubler. 1994. Expression cloning of a human IL-12 receptor component: a new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol. 153:128.
24. Moses, H. L., E. Y. Yang, and J. A. Pietenpol. 1990. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights (minireview). Cell 63: 245.
25. Espevik, T., I. S. Figari, M. R. Shalaby, G. A. Lackides, G. D. Lewis, H. M. Shepard, and M. P. Palladino, Jr. 1987. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J. Exp. Med. 166:571.
26. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037.
27. Ranges, G. E., I. S. Figari, T. Espevik, and M. A. Palladino. Jr. 1987. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J. Exp. Med. 166:991.
28. Fontana, A., H. Hengartner, N. de Tribolet, and E. Weber. 1984. Glioblastoma cells release interleukin-1 and factors inhibiting interleukin-2 mediated effects. J. Immunol. 132:1837.
29. Ruegemer, J. J., S. N. Ho, J. A. Augustine, J. W. Schlager, M. P. Bell, D. J. McKean, and R. T. Abraham. 1990. Regulatory effects of transforming growth factor-β on IL-2 and IL-4 dependent T cell-cycle progression. J. Immunol. 144: 1767.
30. Su, H. C., K. A. Leite-Morris, L. Braun, and C. A. Biron. 1991. A role for transforming growth ractor-β1 in regulating natural killer and T cell lymphocyte proliferative response during acute infection with lymphocyte choriomeningitis virus. J. Immunol. 147:2717.
31. Fontana, A., K. Frei, S. Bodmer, E. Hofer, M. H. Shreiber, M. A. Palladino, Jr., and R. M. Zinkernagel. 1989. Transforming growth factor-β inhibits the generation of cylotoxic T cells in virus-infected mice. J. Immunol. 143:3230.
32. Chouaib, S., J. Chehimi, L. Bani, N. Genetet, T. Tursz, F. Gay, G. Trinchieri, and F. Mami-Chouaib. 1994. Interleukin-12 induces the differentiation of major his tocompaubility complex class I-primed cytotoxic T-Iymphocyte precursors into allospecific cytotoxic effectors. Proc. Natl. Acad. Sci. USA 91:12659.
33. Chouaib, S., J. Bertoglio, J. Y. Blay, C. Marchiol, and D. Fradelizi. 1988. Lymphokine-activated killer generation pathways: synergy between tumor necrosis factor and interleukin-2. Proc. Natl. Acad. Sci. USA 85:6675.
34. Robinet, E., D. Branellec, A. M. Termijtelen, J. Y. Blay, F. Gay, and S. Chouaib. 1990. Evidence for tumor necrosis factor-α involvement in the optimal induction of class I allospecific cytotoxic T cells. J. Immunol. 144:4555.
35. Flament, C., A. Benmerah, M. Bonneville, F. Triebel, and F. Mami-Chouaib. 1994. Human TCR-γ/δ alloreactive response to HLA-DR molecules: comparison with response to TCR α/β. J. Immunol. 153:2890.
36. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes (review). Blood 84:4008.
37. Snijders, A., K. M. U. Hilkens, T. C. T. M. van der Pouw Kraan, M. Engel, L. A. Aarden, and M. L. Kapsenberg. 1996. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156:1207.
38. Chantry, D., M. Turner, E. Abney, and M. Feldman. 1989. Modulation of cytokine production by transforming growth factor-β. J. Immunol. 142:4295.
39. Espinoza-Delgado, I., M. C. Bosco, T. Musso, K. Mood, F. W. Ruscetti, D. L. Longo, and L. Varesio. 1994. Inhibitory cytokine circuits involving transforming growth factor-β, interferon-γ, and interleukin-2 in human monocyte activation. Blood 81:3132.
40. - large granular lymphocyte. J. Immunol. 146:3791.
41. Wu, C. Y., W. W. Warrier, D. M. Carvajal, A. O. Chua, L. J. Minetti, R. Chizzonite, P. K. A. Mongini, A. S. Stern, U. Gubler, D. H. Presky, and M. K. Gately. 1996. Biological function and distribution of human interleukin-12 receptor β chain. Eur. J. Immunol. 26:345.
42. Presky, D. H., U. Gubler, R. A. Chizzonite, and M. K. Gately. 1995. IL-12 receptors and receptor antagonists. Res. Immunol. 146:419.
43. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739.
44. Szabo, S. J., N. G. Jacobson, A. S. Dighe, U. Gubler, and K. M. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665.
45. Hunter, C. A., L. Bermudez, H. Beernink, W. Waegell, and J. S. Remington. 1995. Transforming growth factor-β inhibits interleukin-12-induced production of interferons-γ by natural killer cells: a role for transforming growth factor-β in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25:994.
46. Pazdrak, K., L. Justement, and R. Alam. 1995. Mechanism of inhibition of eosinophil activation by transforming growth factor-β. J. Immunol. 155:4454.
47. Bacon, C. M., D. W. McVicar, J. R. Ortaldo, R. C. Rees, J. J. O'Shea, and J. A. Johnston. 1995. Interleukin-12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J. Exp. Med. 181:399.
48. Mizoguchi, H., J. J. O'Shea, D. L. Longo, C. M. Loeffler, D. W. McVicar, and A. C. Ochoa. 1992. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258:1795.